VYNE Therapeutics Inc. - VYNE

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$9.374M
QoQ value delta ($000)
+$902K (+10.65%)
Implied price effect (QoQ)
+8.32%
Shares
Total shares
14,515,591
QoQ shares delta
+305,205 (+2.15%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (VYNE)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 46 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
ADAR1 Capital Management, LLC 1,919 2,950,000 0.09%
Nantahala Capital Management, LLC 1,301 2,000,000 0.04%
Lynx1 Capital Management LP 1,059 1,628,700 0.12%
Shay Capital LLC 947 1,456,651 0.06%
T3 Companies, LLC 614 945,000 0.66%
Deeter Investments LLP 597 1,000,000 0.07%
BRAIDWELL LP 596 916,077 0.02%
KVP Capital Advisors, LP 325 500,551 0.24%
CITADEL ADVISORS LLC 304 468,457 0.0%
TWO SIGMA INVESTMENTS, LP 285 438,818 0.0%
ACADIAN ASSET MANAGEMENT LLC 248 381,797 0.0%
Ikarian Capital, LLC 172 264,912 0.02%
VANGUARD CAPITAL MANAGEMENT LLC 172 264,557 0.0%
GEODE CAPITAL MANAGEMENT, LLC 168 258,203 0.0%
VANGUARD FIDUCIARY TRUST CO 119 183,443 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 77 118,957 0.0%
Rangeley Capital, LLC 73 113,064 0.07%
XTX Topco Ltd 51 78,721 0.0%
GSA CAPITAL PARTNERS LLP 47 71,533 0.0%
SUPERSTRING CAPITAL MANAGEMENT LP 39 61,269 0.02%
UBS Group AG 38 58,597 0.0%
STALEY CAPITAL ADVISERS INC 33 51,472 0.0%
NORTHERN TRUST CORP 28 43,677 0.0%
BlackRock, Inc. 28 44,405 0.0%
JANE STREET GROUP, LLC 26 40,974 0.0%